EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials

Marguerite Thorp, Kelvin Balakasi, Joep J van Oosterhout, Mira Ramesh, Isabella Robson, Augustine Choko, Steve Shoptaw, Risa Hoffman, Morna Cornell, Kathryn Dovel

AIDS and Behavior · 15.11.2026

DOI: 10.1007/s10461-026-05328-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS and Behavior, online erschienen am 15.11.2026. Verfasst von Marguerite Thorp und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of California, Los Angeles, USA. mthorp@mednet.ucla.edu. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for AIDS Research, University of California Los Angeles, Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mobility is a key risk factor for interruption in HIV treatment (IIT). However, little is known about which aspects of mobility confer greatest risk (i.e., comprise high-risk mobility) and whether people prone to high-risk mobility can be identified prior to events. We conducted a secondary analysis of the IDEaL and ENGAGE trials (ClinicalTrials.gov #NCT04858243; #NCT05137210), which tested interventions to improve 6-month ART engagement among men living with HIV (MLHIV; ≥ 15 years old) not in care (i.e., ART naïve or missed refill by ≥ 28 days) in Malawi. We used baseline and endline (4–7 months post-enrollment) surveys and medical chart reviews of established ART clients experiencing IIT at enrollment who re-initiated ART during trials. We used Poisson regressions with random effects and receiver operator characteristic (ROC) curves to identify mobility characteristics most strongly associated with repeat IIT ( ≥ 28 days late for ART appointment during 6-month trial period) and to identify associated baseline characteristics. Of 1,119 men, 454 (41%) experienced repeat IIT; 314 (28%) took ≥ 3-night trips during the 6-month trial period. Trips ≥ 30 nights (aIRR 1.51, 95%CI 1.14–1.99, AUC 0.648) and lasting longer than expected (aIRR 1.50, 95%CI 1.15–1.96, AUC 0.653) best predicted repeat IIT (specificity 90%). No sociodemographic or pre-trial mobility variables were independently associated with high-risk mobility during the trial period. Mobility is a key risk factor for IIT among men in Malawi, and we found “high-risk mobility” to be trips ≥ 30 nights and/or that lasted longer than expected. We were unable to predict which men would experience high-risk mobility.

Schlagwörter

Stichwörter der Autor:innen

Antiretroviral therapyGeographic mobilityHIV infectionHighly activeMalawiMedication adherence

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of California, Los Angeles, USA. mthorp@mednet.ucla.edu.
  • Partners in Hope, Lilongwe, Malawi.
  • Division of Infectious Diseases, University of California, Los Angeles, USA.
  • Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
  • Liverpool Wellcome Research Program, Blantyre, Malawi.
  • Department of Family Medicine, University of California, Los Angeles, USA.

Förderung

  • Center for AIDS Research, University of California Los Angeles
  • Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles
  • NIMH NIH HHS
  • Bill and Melinda Gates Foundation
  • FIC NIH HHS
  • National Institute of Mental Health
  • Fogarty International Center

Zitieren

APA

Thorp, M., Balakasi, K., van Oosterhout, J. J., Ramesh, M., Robson, I., Choko, A., Shoptaw, S., Hoffman, R., Cornell, M., & Dovel, K. (2026). High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials. AIDS and Behavior. https://doi.org/10.1007/s10461-026-05328-7

Vancouver

Thorp M, Balakasi K, van Oosterhout JJ, Ramesh M, Robson I, Choko A, et al. High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials. AIDS and Behavior. 2026. doi:10.1007/s10461-026-05328-7

BibTeX
@article{Thorp2026,
  author = {Thorp, Marguerite and Balakasi, Kelvin and van Oosterhout, Joep J and Ramesh, Mira and Robson, Isabella and Choko, Augustine and Shoptaw, Steve and Hoffman, Risa and Cornell, Morna and Dovel, Kathryn},
  title = {High-Risk Mobility and Interruption in HIV Treatment Among Men in Malawi: Secondary Analysis of Two Randomized Controlled Trials},
  journal = {AIDS and Behavior},
  year = {2026},
  doi = {10.1007/s10461-026-05328-7}
}
Kostenlos starten →